Recognizing and Reversing Insulin Resistance: The Silent Engine Behind Belly Fat
Your fasting blood sugar can stay unremarkable for years while your insulin is already working at full throttle. If you measure insulin directly, you can recognize insulin resistance earlier. And when caught early, it could often be improved considerably in studies.
A normal fasting blood sugar is good news. But it is not a clean bill of health. Blood sugar is often the last thing to tip over. Before that, your insulin has often been working in secret for years. If you measure it, you can see sooner. And if you see sooner, you have more room to move.
You are standing in front of the mirror. Your arms are as slim as ever, your face has barely changed. Only your belly has quietly pushed its way forward over the last few years.
You are not eating more than you used to. Maybe even less. And yet your waistband feels tight. In the afternoon your energy slumps, and you reach for the chocolate as if on autopilot.
Then come the results from your check-up: fasting blood sugar unremarkable. Everything in the green zone. And you wonder why it doesn't feel that way.
May I ask you an uncomfortable question? What if your blood sugar is only normal because your body is working overtime in the background?
In the article Insulin resistance and weight loss, I described why the kilos often stay put with insulin resistance. This text starts one step earlier. It is about how you can recognize insulin resistance before your blood sugar rises. Which values reveal more than fasting blood sugar. And what large studies say about whether it can be reversed.
One thing up front: this text does not replace a medical examination. It is meant to help you ask the right questions.
What to expect in this article
- The pattern: slim arms, big belly
- Why fasting blood sugar often raises the alarm too late
- Fasting insulin, the HOMA index and the insulin curve
- Triglycerides, HDL, the TyG index and your waist as clues
- Why belly and liver fat have so much say
- Whether insulin itself can be an engine for belly fat
- What large studies show about reversal
- Three levers and twelve answers to common questions
Slim arms, big belly: how do you recognize the pattern?
Some people carry their weight evenly. Others look slim from a distance. Only in profile do you notice that everything collects in the middle. I come across this second picture strikingly often in my practice when insulin has fallen out of rhythm.
“My arms are as thin as ever. Only my belly keeps growing.”
I know this pattern very well. What I describe here is pieced together from several cases and changed so that no one can be recognized.
A man in midlife, sporty in the past, now spending a lot of time at a desk. What he said in our first conversation: “My arms are as thin as ever. But my belly keeps growing, and I don't understand why. At my check-up they said: blood sugar fine.”
We measured his fasting blood sugar again and also his fasting insulin. His blood sugar was in the normal range again. His insulin was well above it, and the HOMA index showed clear insulin resistance. His triglycerides were elevated, and his waist circumference was more than half his height.
The turning point was not a new diet. It was an image: his blood sugar was only normal because his pancreas was working overtime in the background. That image moved him more than any number on the scale. Step by step, he reorganized his exercise, sleep and mealtimes, without a crash diet.
At the follow-up a few months later, his insulin had dropped considerably. His belt was fastened one notch tighter.
The lesson: His normal blood sugar was not an all-clear. It was a sign of how hard his body was working.
Around one in five normal-weight adults is metabolically unhealthy and carries a more than threefold higher risk of death or cardiovascular events (Stefan 2017).
This story does not stand alone. The scale measures your weight. It does not measure where the fat sits and what it does there. And that is exactly what can be decisive for your insulin.
Normal weight, yet metabolically unwell
Review, human dataStefan, Schick and Häring from Tübingen University Hospital and the German Center for Diabetes Research summarized the evidence on slim people with an unhealthy metabolism. According to their review, about 20 percent of normal-weight adults are metabolically unhealthy and have a more than threefold higher risk of death or cardiovascular events than metabolically healthy people of normal weight. For you, this means: your BMI can reassure you while your metabolism is already sending signals.
Stefan N, Schick F, Häring HU. Cell Metab. 2017;26(2):292-300. DOI: 10.1016/j.cmet.2017.07.008Why does location matter so much? Imagine the fat under your skin as a large wardrobe. It is built to store supplies neatly. If the wardrobe is full or badly organized, things end up in the hallway. In the body, this hallway is the abdominal cavity, the liver and the muscles. Experts speak of ectopic fat, meaning fat in the wrong place.
Liver fat may tip the balance
Metabolic study in humansA team at Washington University in St. Louis led by Fabbrini and Klein compared people with obesity who had the same amount of belly fat but different amounts of liver fat. With more liver fat, insulin sensitivity was 41 percent lower in the liver, 13 percent lower in fat tissue and 36 percent lower in muscle, whereas with the same liver fat and different amounts of belly fat, no difference was found. For you, this means: a liver that has also become fatty may matter even more for your insulin than the sheer amount of belly fat.
Fabbrini E, Magkos F, Mohammed BS, et al. Proc Natl Acad Sci U S A. 2009;106(36):15430-5. DOI: 10.1073/pnas.0904944106You don't need an MRI for a first look. An international expert panel led by Ross calls for waist circumference to be measured in every practice as a standard vital sign, because BMI alone does not adequately reflect risk. The panel's good news: even moderate exercise and dietary changes can noticeably reduce waist circumference (Ross 2020).
The ratio of waist to height may be even more telling. A systematic review of 78 studies found the same guide value for men and women: 0.5. Its message is refreshingly simple: keep your waist circumference below half your height (Browning 2010). A meta-analysis with data from more than 300,000 adults showed that this ratio indicated diabetes and high blood pressure better than BMI and waist circumference alone (Ashwell 2012).
Your two-minute self-check
- Waist divided by height: Measure while standing, after a relaxed breath out, midway between your lowest rib and the top of your hip bone. If you are 1.80 meters tall, half of that is 90 centimeters.
- The pattern: Your belly grows while your arms and legs stay slim.
- After meals: Tiredness, grogginess or an energy slump in the afternoon.
- Your skin: Dark, velvety patches on the neck or in the armpits, many small skin tags.
- Your last lab results: Elevated triglycerides, low HDL, raised liver values or a fatty liver on ultrasound.
- Your family: Type 2 diabetes in parents or siblings.
None of these signs proves insulin resistance. If several apply, that is a good reason to get specific tests done.
Your belly is not a character flaw. It can be a measuring instrument that shows you, earlier than some lab values, that your metabolism is under pressure.
And now you know why a tape measure sometimes reveals more than a scale.
Why does fasting blood sugar raise the alarm so late in insulin resistance?
Imagine carrying a backpack every day that gets heavier week by week. At first you notice nothing. You walk a little more upright, tense more muscles, compensate. From the outside, nobody sees you wobble. Until one day you stumble.
Something similar can happen to your glucose metabolism. And that is why an unremarkable fasting blood sugar can be deceptive.
In the Whitehall II study, fasting blood sugar only began to rise steeply about three years before the diabetes diagnosis, while insulin sensitivity had already fallen markedly before that (Tabák 2009).
Insulin is the key that unlocks the door of your cells for sugar. With insulin resistance, the locks in muscle, liver and fat tissue stick. Your pancreas reacts the way a hard-working caretaker would: it sends more keys. Sugar keeps getting into the cells. Just with more and more effort.
This is exactly where the blind spot lies. Fasting blood sugar measures the result, not the effort. As long as the caretaker can manage the overtime, the result stays unremarkable.
Blood sugar only rises steeply late
Cohort, n=6,538A team at University College London led by Tabák followed 6,538 British civil servants without diabetes for a median of 9.7 years, and 505 of them developed diabetes. In these people, fasting blood sugar only began to rise steeply about three years before the diagnosis, from 5.79 to 7.40 mmol/L, or from about 104 to 133 mg/dL, while insulin sensitivity had already been falling markedly during the five years before the diagnosis. For you, this means: by the time your blood sugar visibly rises, the change in the background may have been underway for years.
Tabák AG, Jokela M, Akbaraly TN, et al. Lancet. 2009;373(9682):2215-21. DOI: 10.1016/S0140-6736(09)60619-XOne detail from the same study is fascinating. Between the fourth and the third year before the diagnosis, insulin production actually rose further, from 85.0 to 92.6 percent. Only after that did it fall, reaching 62.4 percent by the time of diagnosis (Tabák 2009). That is the caretaker giving it everything one last time.
Researchers at the US National Institutes of Health (NIH) in Phoenix led by Weyer tracked what this compensation looks like over several years. They followed members of the Pima people in Arizona with elaborate metabolic measurements. In those who stayed healthy, the insulin response rose as insulin sensitivity fell. In those who developed diabetes, insulin sensitivity and insulin secretion declined together (Weyer 1999).
Four phases, simplified
The locks stick
The cells respond less strongly to insulin. The pancreas releases more. Fasting blood sugar stays unremarkable.
The caretaker works overtime
Fasting insulin and the HOMA index can rise considerably. Belly fat and liver fat often increase. Blood sugar is still in the normal range.
Prediabetes
The capacity to compensate wanes. Fasting blood sugar, HbA1c or the glucose tolerance test are above the normal range.
Type 2 diabetes
The pancreas can no longer meet the extra demand. Only now does blood sugar rise markedly.
Simplified model based on cohort data (Weyer 1999, Tabák 2009). Not everyone goes through every phase, and the course can be influenced in every phase.
High insulin with normal blood sugar as an early warning light
Cohort, n=515, 24 yearsA team at the Gertner Institute in Israel led by Dankner re-examined 515 adults with normal blood sugar after 24 years. By then, half had developed a disorder of glucose metabolism and 24.3 percent had type 2 diabetes, and the strongest predictor was a fasting insulin in the top fifth, independent of BMI, age, physical activity, blood pressure and triglycerides. For you, this means: high insulin with normal blood sugar can be an early warning light, long before blood sugar itself stands out.
Dankner R, Chetrit A, Shanik MH, Raz I, Roth J. Diabetes Care. 2009;32(8):1464-6. DOI: 10.2337/dc09-0153A normal fasting blood sugar can mean two things. Your metabolism is relaxed. Or it is working very hard to make it look that way. Your insulin can tell you which of the two applies.
And now you know why fasting blood sugar tends to tell the end of a story rather than its beginning.
Fasting insulin, HOMA and the insulin curve: which values show it earlier?
Maybe you are picturing your last lab report right now. Glucose, HbA1c, cholesterol. And you look in vain for insulin. That is not an oversight. It is routine.
Standard testing with fasting blood sugar, HbA1c and the glucose tolerance test is well researched and makes sense. It is designed to reliably identify prediabetes and diabetes. For the phase before that, functional medicine also looks at insulin itself.
In a large database of glucose tolerance tests, around half of the people with normal glucose tolerance still showed an excessive insulin pattern (Crofts 2016).
Standard: finds prediabetes and diabetes
- Fasting blood sugar
- HbA1c, the long-term blood sugar of roughly the last three months
- Glucose tolerance test with glucose values
- Lipid profile with triglycerides and HDL
Functional additions: looking for the phase before
- Fasting insulin, from the same blood draw as the glucose
- HOMA index from both values
- Glucose tolerance test with insulin curve
- Triglyceride-to-HDL ratio and TyG index
- Waist-to-height ratio
- Liver values, and a liver ultrasound if needed
The HOMA index: a simple calculation that says a lot
The HOMA index was described in 1985 by Matthews and colleagues. It uses fasting blood sugar and fasting insulin to estimate how strongly your cells respond to insulin. Compared with the elaborate gold standard, the clamp test, it agreed closely, with a correlation of 0.88. In individual cases, however, its precision was limited, with a variation of about 31 percent (Matthews 1985).
HOMA-IR = fasting insulin (µU/mL) × fasting glucose (mg/dL) ÷ 405
Person A
Glucose 90 mg/dL
Insulin 5 µU/mL
Person B
Glucose 90 mg/dL
Insulin 18 µU/mL
Same fasting blood sugar. More than three times as much insulin. On a standard lab report, both would look the same.
Where is the cut-off?
Let's be honest here: there is no single worldwide cut-off. Insulin is measured with different test methods depending on the laboratory. As early as 2003, a team at Stanford University noted that a standardized insulin test is lacking (McLaughlin 2003).
A Spanish population study of 2,459 adults shows how much the cut-off depends on the method. If you simply counted the top ten percent as abnormal, it was 3.46. When actual metabolic risk was taken into account, it dropped to 2.05, and to 1.85 in men without diabetes (Gayoso-Diz 2013).
What I observe clinically: a HOMA value above about 2 with unremarkable blood sugar is a reason for me to take a closer look. That is a guide from clinical practice, not a diagnostic criterion. A single value can fluctuate. That is why it always belongs in context with waist size, blood lipids and symptoms.
The insulin curve: what its course can reveal
Normal glucose tolerance, yet too much insulin
Cohort, retrospective, n=4,185Researchers at Auckland University of Technology led by Crofts, together with Kraft from St. Joseph Hospital in Chicago, analyzed glucose tolerance tests with simultaneous insulin measurements from the 1970s to the 1990s. Of 4,185 people with normal glucose tolerance, 2,079, or around half, still showed an excessive insulin pattern, and fasting insulin alone detected this pattern only to a limited extent. For you, this means: even an unremarkable fasting insulin is not a full all-clear, and the course after a glucose drink can show more.
Crofts C, Schofield G, Zinn C, Wheldon M, Kraft J. Diabetes Res Clin Pract. 2016;118:50-7. DOI: 10.1016/j.diabres.2016.06.007The timing of the insulin peak may also matter. A team from Seattle led by Hayashi followed 400 Japanese American women and men without diabetes for 10 to 11 years. If insulin only reached its peak after two hours in the glucose tolerance test, 37.5 to 47.8 percent developed diabetes, depending on the shape of the curve. If the peak came early, at 30 minutes, the figure was 3.2 to 9.8 percent (Hayashi 2013).
An honest assessment: Fasting insulin and the insulin curve are not part of guideline-based diabetes testing, which relies on blood sugar and HbA1c. There are no generally accepted cut-offs for the insulin curve. I use it in a targeted way when waist size, blood lipids or symptoms don't match an unremarkable blood sugar. PCOS comes with its own particular features, which I have described in Recognizing and measuring insulin resistance in PCOS.
Two clues that are already on your lab report
A team at Stanford University led by McLaughlin and Reaven examined 258 overweight adults without diabetes using an elaborate insulin suppression test. Apart from insulin itself, two simple values identified the insulin-resistant participants best: triglycerides of 130 mg/dL or higher and a triglyceride-to-HDL ratio of 3.0 or higher. Both were right in about two out of three cases (McLaughlin 2003).
The TyG index combines triglycerides and fasting blood sugar into one number. In a meta-analysis of 14 cohort studies with 270,229 people, a high TyG index was associated with an approximately 3.5-fold higher risk of diabetes. From a value of about 8.6, the risk curve became markedly steeper (Pranata 2021).
A glucose sensor can also show how your blood sugar responds to meals in everyday life. It does not replace a diagnosis, but it can make patterns visible. With your first sensor, it is worth having it applied and evaluated with guidance. More on this in Blood sugar and weight loss: what a CGM sensor shows.
No single value is perfect. But several blurry pictures laid on top of each other can produce a surprisingly clear image.
And now you know why I still ask about insulin when blood sugar is unremarkable.
Is insulin the silent engine behind belly fat?
Maybe you have already tried a lot. Eating less, running more, counting calories. The scale barely moves, your belly even less. At some point, you start to doubt yourself.
I would like to offer you a different explanation. Not as an excuse, but as a map.
In an analysis with data from more than 300,000 people, those with a genetically higher insulin release after sugar had a higher BMI on average (Astley 2018).
Insulin is not only the key for sugar. It is also a signal: time to store. As long as insulin is high, it slows the breakdown of fat from the fat cells. Imagine high insulin as a bouncer who happily lets fat in but hardly lets anyone out.
This can create a cycle. Belly and liver fat release fatty acids and messenger substances that can increase insulin resistance. The pancreas responds with even more insulin. And more insulin can in turn mean more storage. How insulin interacts with the satiety hormone leptin is described in the article Leptin and insulin.
A natural lottery points to insulin as a player
Mendelian randomizationA team from Boston led by Astley, Ludwig and Florez used genetic variants as a kind of natural lottery and analyzed data from large genetic studies and the UK Biobank. People with a genetically higher insulin release 30 minutes after sugar had a higher BMI on average, whereas a genetically higher BMI was not, conversely, associated with more insulin release. For you, this means: insulin could be not only a consequence but also a contributing cause of excess weight, although the carbohydrate-insulin model that these results fit with is controversial in research.
Astley CM, Todd JN, Salem RM, et al. Clin Chem. 2018;64(1):192-200. DOI: 10.1373/clinchem.2017.280727Less insulin, lean mice
In vivo, mouseIn an animal study in mice, a team at the University of British Columbia led by Mehran and Johnson genetically reduced the insulin production of the pancreas. Despite a high-fat diet, these mice stayed fully protected from diet-induced obesity, their white fat tissue burned more energy, and inflammation and fatty liver were less pronounced. For you, this means: in the animal model, too much insulin can drive weight gain, but in humans this has not yet been conclusively proven.
Mehran AE, Templeman NM, Brigidi GS, et al. Cell Metab. 2012;16(6):723-37. DOI: 10.1016/j.cmet.2012.10.019For context: Whether insulin rises first or fat grows first has not been conclusively settled by science. The carbohydrate-insulin model is the subject of controversial debate in research. There is a lot to suggest that insulin and belly fat reinforce each other. The good news in this: a cycle can be interrupted at several points.
Metabolism
Your liver is your sugar store for the night. If it becomes fatty, it can respond less strongly to insulin and release too much sugar into the blood even in the fasting state. The pancreas responds with even more insulin.
Immune system
Scavenger cells of the immune system gather in growing fat tissue. In mice, these macrophages produced almost all of the fat tissue's TNF-alpha, and in human fat tissue, too, their number increased with the size of the fat cells (Weisberg 2003). Inflammatory messengers like these can disrupt insulin signaling.
Hormonal system
Insulin does not work alone. Persistently elevated cortisol can raise blood sugar and favor fat storage around the belly. In women, insulin is closely linked to the sex hormones, and in men to testosterone.
Nervous system
Sleep is metabolic time. After four nights with only 4.5 hours in bed, the fat cells of healthy young people needed almost three times as much insulin for the same signaling response (Broussard 2012). Chronic stress can also keep the alarm system active that makes sugar available.
How closely insulin is linked to your hormones is explored in more depth in the articles Insulin resistance and female hormones, Excess weight, insulin resistance and testosterone and Blood sugar and cortisol. You can read about the role of silent inflammation in Silent inflammation and weight.
A second perspective comes from anthroposophic medicine. It also understands health as rhythm: waking and sleeping, eating and pausing, tension and relaxation. A metabolism that has to release insulin from morning until late at night hardly gets a break anymore. That is a way of thinking, not a study result. But early studies on meal timing and sleep fit well with it (Sutton 2018, Broussard 2012).
Belly fat is not just a storage depot. It is an active organ that talks to your liver, your immune system and your hormones. Once you understand that, you can stop fighting your own body and start negotiating with it.
And now you know why fewer calories alone sometimes don't get through to your belly.
Can insulin resistance be reversed?
Maybe you are thinking right now: fine, now I know what is going on inside me. But can I still change anything about it?
Here, the evidence is decidedly encouraging. And it does not come from small niches, but from some of the largest prevention trials in medicine.
In two large randomized trials, a lifestyle program lowered the risk of diabetes in people with prediabetes by 58 percent each (Knowler 2002, Tuomilehto 2001).
Diabetes Prevention Program: lifestyle ahead of medication
RCT, n=3,234The Diabetes Prevention Program in the US randomly assigned 3,234 people with elevated blood sugar but without diabetes to placebo, the prescription drug metformin or a lifestyle program. The program aimed for at least 7 percent weight loss and at least 150 minutes of physical activity per week, and after an average of 2.8 years, it lowered the risk of diabetes by 58 percent, while metformin lowered it by 31 percent. For you, this means: in prediabetes, even a moderate change can make a big difference, and the lifestyle program actually performed better than the medication.
Knowler WC, Barrett-Connor E, Fowler SE, et al. N Engl J Med. 2002;346(6):393-403. DOI: 10.1056/NEJMoa012512At almost the same time, the Finnish Diabetes Prevention Study with 522 overweight people reached the same result: minus 58 percent. In the first year, participants had lost only a little over 4 kilos on average (Tuomilehto 2001). A meta-analysis of seven randomized trials with 4,090 people confirms the effect and shows that it can last for many years after the programs end (Uusitupa 2019).
And if diabetes is already there?
DiRECT: remission in primary care
RCT, cluster-randomized, n=306In the DiRECT trial led by Lean and Taylor, 306 people who had had type 2 diabetes for no more than six years and were treated in primary care practices in Scotland and the northeast of England either took part in a structured weight management program with a formula diet lasting several months or received usual care. After twelve months, 46 percent of the program group were in remission without diabetes medication, compared with 4 percent in the control group, and among those who lost 15 kilos or more, the figure was 86 percent. For you, this means: even established type 2 diabetes can go into remission, and in prediabetes the room for change is probably even greater.
Lean MEJ, Leslie WS, Barnes AC, et al. Lancet. 2018;391(10120):541-551. DOI: 10.1016/S0140-6736(17)33102-1A team at Newcastle University led by Lim and Taylor used MRI to make visible what happens in the body. Eleven people with type 2 diabetes ate a very low-calorie diet for eight weeks. After just one week, their fasting blood sugar fell from 9.2 to 5.9 mmol/L. Liver fat fell from 12.8 to 2.9 percent by week eight, and the early insulin response of the pancreas moved closer to that of healthy people (Lim 2011). The liver seems to be a key place where insulin resistance can ease first. You can read how sugar and fructose can strain the liver in Sugar, fructose and the liver.
Important: in the studies, very low-calorie programs like these were carried out under professional supervision, and medications were adjusted in a controlled way. Please never try this on your own, especially not if you take diabetes medication.
Belly fat can shrink before the scale shows it
Exercise can do more for your belly than for the scale
Meta-analysis, 117 studies, n=4,815A team at Radboud University in Nijmegen led by Verheggen pooled 117 studies with 4,815 people that had measured belly fat using imaging. Dieting lowered weight more, while exercise training tended to lower belly fat more, and without weight loss, exercise training was associated with 6.1 percent less belly fat, dieting with only 1.1 percent. For you, this means: the scale can stand still while your belly fat is already shrinking.
Verheggen RJHM, Maessen MFH, Green DJ, et al. Obes Rev. 2016;17(8):664-90. DOI: 10.1111/obr.12406A randomized study from the University of Sydney shows how quickly things can change. Four weeks of endurance training on a bike lowered belly fat by 12 percent and liver fat by 21 percent in 19 people with obesity. Their weight did not change (Johnson 2009). The HOMA index, however, stayed the same during these four weeks, a sign that insulin values may need more time.
Strength training can make its own contribution. In a randomized study at Newcastle University, eight weeks of strength training lowered liver fat by a relative 13 percent. The HOMA index improved from 5.9 to 4.6, also without weight loss (Hallsworth 2011). You can find more on this in Strength training for diabetes and insulin resistance.
Timing can matter too
Eating earlier, same weight, better insulin
RCT, crossoverA team at the Pennington Biomedical Research Center in Louisiana led by Sutton and Peterson had men with prediabetes eat all their meals within a six-hour window for five weeks, with dinner before 3 p.m., and compared this with a twelve-hour window. With enough food for their weight to stay stable, insulin sensitivity, the response of the beta cells, blood pressure and appetite improved. For you, this means: when you eat can also matter for your insulin, although this was an early feasibility study in men.
Sutton EF, Beyl R, Early KS, et al. Cell Metab. 2018;27(6):1212-1221.e3. DOI: 10.1016/j.cmet.2018.04.010You can read how fasting can influence blood sugar and who it suits in Fasting, blood sugar and insulin resistance.
Recognizing it early means having room to move
This is not about a flatter belly. It is about the years ahead of you. Recognizing insulin resistance early means being able to make decisions while you still have a choice. Before your pancreas gets tired. Before a signal turns into a diagnosis. Health is not just the absence of findings. Health is room to move.
Insulin resistance is not a verdict, but a state. And states can change, especially if you notice them early.
And now you know why it is worth taking prediabetes seriously: this is where your lever is longest.
Three levers you can start with this week
Maybe this is a lot at once. Numbers, curves, studies. Take a breath. You don't have to change everything at the same time.
Measure instead of guessing
Take a tape measure today and divide your waist by your height. If the value is above 0.5, or your belly doesn't match your unremarkable blood sugar, ask about fasting insulin, the HOMA index, triglycerides and HDL at your next blood test.
Give your muscles work
A walk after your largest meal and two strength sessions a week can open up an additional route for sugar into your muscles. This way, belly and liver fat can decrease, even while the scale is still standing still. You can find ideas in Exercise after meals.
Give your metabolism rhythm
Protect your sleep and have your last meal earlier rather than later. Even a few short nights can measurably lower insulin sensitivity, and earlier mealtimes showed favorable effects in early studies. More on this in Sleep and weight loss.
You don't have to be perfect. It is enough to give your body a few signals each day that are different from yesterday's.
If you take medication that lowers blood sugar, especially insulin or sulfonylureas, fasting, formula diets or eating far fewer carbohydrates can lead to dangerously low blood sugar. Only make changes like these with medical supervision. This also applies during pregnancy, with eating disorders and with kidney or liver disease. Metformin and weight loss injections such as semaglutide or tirzepatide are prescription-only and belong in a doctor's hands. You can find background in Weight loss injections: what they can and cannot do. This text deliberately contains no dosages. If you have severe thirst, frequent urination or unintended weight loss, have your blood sugar checked by a doctor promptly.
And now you know why: your blood sugar tells you where you stand. Your insulin can tell you where you are heading. If you know both, you can change direction in time.
Frequently asked questions about insulin resistance
What is insulin resistance, in simple terms?
Insulin resistance means that your cells respond less strongly to insulin. Insulin is the key that lets sugar pass from the blood into muscle, liver and fat tissue. When the locks stick, the pancreas releases more insulin so that blood sugar still stays within range. This extra work can go on unnoticed for years. Only when it is no longer enough does blood sugar rise into the range of prediabetes or diabetes (Weyer 1999, Tabák 2009).
Can I have insulin resistance even though my fasting blood sugar is normal?
Yes, in the early phase this is actually typical. For a long time, the body keeps blood sugar within range with extra insulin. In the Whitehall II study, fasting blood sugar only began to rise steeply about three years before the diabetes diagnosis (Tabák 2009). In a large database, around half of the people with normal glucose tolerance still showed an excessive insulin pattern (Crofts 2016). That is why looking at insulin itself can be worthwhile.
How do I calculate the HOMA index?
The HOMA index uses fasting blood sugar and fasting insulin to estimate how insulin resistant you are (Matthews 1985). The common approximation is: fasting insulin in µU/mL times fasting glucose in mg/dL, divided by 405. An example: a glucose of 90 mg/dL and an insulin of 5 µU/mL give about 1.1, while the same glucose with an insulin of 18 µU/mL gives 4.0. Both values should come from the same fasting blood draw. Because a single value can fluctuate, a repeat test is worthwhile if a result stands out.
What HOMA value counts as insulin resistance?
There is no single worldwide cut-off, because insulin tests are not fully standardized and populations differ. In a Spanish study of 2,459 adults, the threshold above which metabolic risk accumulated was 2.05, and 1.85 in men without diabetes (Gayoso-Diz 2013). Many laboratories state their own guide values. Clinically, I take a value above about 2 with unremarkable blood sugar as a reason to look more closely. That is clinical experience, not a firm diagnostic criterion.
Why isn't fasting insulin measured routinely?
In the guidelines, the diagnosis of prediabetes and diabetes is based on fasting blood sugar, HbA1c and the glucose tolerance test. These values are well standardized and linked to long-term complications. Insulin is measured with different methods depending on the laboratory, and a standardized test is lacking (McLaughlin 2003). Functional medicine therefore uses insulin not as a diagnosis, but as a possible early warning signal that is read together with waist size, blood lipids and symptoms.
How can I recognize insulin resistance without lab tests?
An important clue is your waist. If your waist circumference is more than half your height, meaning a ratio above 0.5, the risk of diabetes and cardiovascular disease rises (Browning 2010). Other possible signs are tiredness after meals, cravings in the afternoon, dark, velvety patches of skin on the neck or in the armpits, and a belly that grows while arms and legs stay slim. None of these signs is proof. Several together are a good reason to get specific tests done.
Does insulin resistance make you gain fat around the belly?
Insulin resistance and belly fat can reinforce each other. High insulin can promote fat storage and slow fat breakdown, while a fatty liver can drive insulin resistance further (Fabbrini 2009). A genetic analysis suggests that a high insulin release after sugar could play a part in shaping body weight (Astley 2018). Whether insulin is more of a cause or a consequence here is still being debated in research. What counts in everyday life: the cycle can be interrupted at several points.
Is it possible to reverse insulin resistance?
Studies show that insulin resistance and its consequences can improve considerably, especially in the early stages. In the Diabetes Prevention Program, a lifestyle program lowered the risk of diabetes by 58 percent in people with prediabetes (Knowler 2002). In the DiRECT trial, 46 percent of people who had had type 2 diabetes for no more than six years went into remission within a year after a structured weight management program (Lean 2018). How much your metabolism changes depends on many factors and only becomes clear over time.
Can insulin resistance improve even without weight loss?
That is possible. In a meta-analysis of 117 studies, exercise training was associated with 6.1 percent less belly fat even without weight loss (Verheggen 2016). In a randomized study, eight weeks of strength training lowered liver fat and improved the HOMA index without any change in weight (Hallsworth 2011). In men with prediabetes, an early eating window improved insulin sensitivity while weight stayed stable (Sutton 2018). So the scale is not the only yardstick.
What do the triglyceride-to-HDL ratio and the TyG index tell you?
Both are simple clues from values that are often measured anyway. For the ratio, you divide your triglycerides by your HDL cholesterol, both in mg/dL. In a Stanford study, a ratio of 3.0 or higher, or triglycerides of 130 mg/dL or higher, identified overweight people with insulin resistance in about two out of three cases (McLaughlin 2003). The TyG index combines triglycerides and fasting blood sugar. In a meta-analysis of 14 cohort studies, a high TyG index was associated with an approximately 3.5-fold higher risk of diabetes, with a steeper rise from about 8.6 (Pranata 2021).
What role does sleep play in insulin resistance?
Sleep can noticeably influence your insulin balance. In a randomized crossover study, the fat cells of healthy young adults needed almost three times as much insulin for the same signaling response after four nights with 4.5 hours in bed, and whole-body insulin sensitivity also fell (Broussard 2012). The study was small, but it fits with many other observations. Getting enough sleep is therefore not a luxury, but part of caring for your metabolism.
What is the difference between insulin resistance and prediabetes?
Insulin resistance describes how strongly your cells respond to insulin. Prediabetes is a diagnosis based on blood sugar: fasting glucose, HbA1c or the glucose tolerance test are above the normal range, but still below the threshold for diabetes. Insulin resistance can precede prediabetes by years (Tabák 2009, Dankner 2009). According to a meta-analysis of randomized trials, if you take action early, you can roughly halve your risk of diabetes, with an effect that can last for many years (Uusitupa 2019).
More articles on weight loss
- Understanding weight holistically: all the building blocks at a glance
- Insulin resistance and weight loss: why the kilos stay
- Leptin and insulin: the hormones that steer your weight
- Blood sugar and weight loss: what a CGM sensor shows
- Avoiding blood sugar spikes: order, combination, timing
- Silent inflammation and weight: the invisible brake
- Why am I not losing weight even though I eat little?
- The calorie myth: quality over quantity
- Cravings: where they come from
- Appetite regulation: understanding hunger and satiety
- Boosting GLP-1 naturally: what the body can do on its own
- Unprocessed food: why whole foods keep you full
- Sleep and weight loss
- Boosting your metabolism: what counts
- The breast milk puzzle: growth despite few calories
- Weight loss injections: what they can and cannot do
- Weight loss injections: the GLP-1 mechanism
- Weight loss injections: putting side effects into context
- Weight loss injections and muscle loss: the risk
- Muscle loss on weight loss injections: protecting your muscles
- Stopping weight loss injections: avoiding the yo-yo effect
- Mounjaro and tirzepatide
Connections to other topics
Hormones · PCOS
Recognizing and measuring insulin resistance in PCOS, including in slim women.
Hormones · Women
How insulin and female hormones can influence each other.
Hormones · Men
How belly fat, insulin resistance and testosterone interact.
Hormones · Cortisol
Why chronic stress can raise your blood sugar.
Exercise · Strength training
Muscle as a glucose store in diabetes and insulin resistance.
Exercise · After meals
How a little movement can flatten blood sugar spikes.
Fasting · Insulin
What fasting can do for blood sugar and insulin resistance, and where its limits lie.
Fasting · Type 2 diabetes
The opportunities and risks of fasting when you already have diabetes.
Nutrition · Liver
How sugar and fructose can strain the liver.
Lab tests · Inflammation
Detecting silent inflammation in the blood: hs-CRP and other markers.
Sources
- Stefan N, Schick F, Häring HU. Causes, Characteristics, and Consequences of Metabolically Unhealthy Normal Weight in Humans. Cell Metab. 2017;26(2):292-300. DOI: 10.1016/j.cmet.2017.07.008 · PMID: 28768170 [Review]
- Fabbrini E, Magkos F, Mohammed BS, et al. Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity. Proc Natl Acad Sci U S A. 2009;106(36):15430-5. DOI: 10.1073/pnas.0904944106 · PMID: 19706383 [Pathophysiology, clamp and tracer study in people with obesity]
- Ross R, Neeland IJ, Yamashita S, et al. Waist circumference as a vital sign in clinical practice: a Consensus Statement from the IAS and ICCR Working Group on Visceral Obesity. Nat Rev Endocrinol. 2020;16(3):177-189. DOI: 10.1038/s41574-019-0310-7 · PMID: 32020062 [Review, consensus statement]
- Browning LM, Hsieh SD, Ashwell M. A systematic review of waist-to-height ratio as a screening tool for the prediction of cardiovascular disease and diabetes: 0·5 could be a suitable global boundary value. Nutr Res Rev. 2010;23(2):247-69. DOI: 10.1017/S0954422410000144 · PMID: 20819243 [Systematic review, 78 studies]
- Ashwell M, Gunn P, Gibson S. Waist-to-height ratio is a better screening tool than waist circumference and BMI for adult cardiometabolic risk factors: systematic review and meta-analysis. Obes Rev. 2012;13(3):275-86. DOI: 10.1111/j.1467-789X.2011.00952.x · PMID: 22106927 [Meta-analysis, 31 studies, more than 300,000 adults]
- Tabák AG, Jokela M, Akbaraly TN, et al. Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: an analysis from the Whitehall II study. Lancet. 2009;373(9682):2215-21. DOI: 10.1016/S0140-6736(09)60619-X · PMID: 19515410 [Cohort, n=6,538, Whitehall II]
- Weyer C, Bogardus C, Mott DM, Pratley RE. The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. J Clin Invest. 1999;104(6):787-94. DOI: 10.1172/JCI7231 · PMID: 10491414 [Cohort, longitudinal with clamp measurements, n=48]
- Dankner R, Chetrit A, Shanik MH, Raz I, Roth J. Basal-state hyperinsulinemia in healthy normoglycemic adults is predictive of type 2 diabetes over a 24-year follow-up: a preliminary report. Diabetes Care. 2009;32(8):1464-6. DOI: 10.2337/dc09-0153 · PMID: 19435961 [Cohort, n=515, 24 years, preliminary report]
- Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412-9. DOI: 10.1007/BF00280883 · PMID: 3899825 [Pathophysiology, methods study with clamp comparison]
- Gayoso-Diz P, Otero-González A, Rodriguez-Alvarez MX, et al. Insulin resistance (HOMA-IR) cut-off values and the metabolic syndrome in a general adult population: effect of gender and age: EPIRCE cross-sectional study. BMC Endocr Disord. 2013;13:47. DOI: 10.1186/1472-6823-13-47 · PMID: 24131857 [Cross-sectional study, n=2,459]
- Crofts C, Schofield G, Zinn C, Wheldon M, Kraft J. Identifying hyperinsulinaemia in the absence of impaired glucose tolerance: An examination of the Kraft database. Diabetes Res Clin Pract. 2016;118:50-7. DOI: 10.1016/j.diabres.2016.06.007 · PMID: 27344544 [Cohort, retrospective database analysis, n=4,185 with normal glucose tolerance]
- Hayashi T, Boyko EJ, Sato KK, et al. Patterns of insulin concentration during the OGTT predict the risk of type 2 diabetes in Japanese Americans. Diabetes Care. 2013;36(5):1229-35. DOI: 10.2337/dc12-0246 · PMID: 23275353 [Cohort, n=400, 10 to 11 years]
- McLaughlin T, Abbasi F, Cheal K, et al. Use of metabolic markers to identify overweight individuals who are insulin resistant. Ann Intern Med. 2003;139(10):802-9. DOI: 10.7326/0003-4819-139-10-200311180-00007 · PMID: 14623617 [Cross-sectional study, n=258, insulin suppression test]
- Pranata R, Huang I, Irvan, Lim MA, Vania R. The association between triglyceride-glucose index and the incidence of type 2 diabetes mellitus: a systematic review and dose-response meta-analysis of cohort studies. Endocrine. 2021;74(2):254-262. DOI: 10.1007/s12020-021-02780-4 · PMID: 34086260 [Meta-analysis, 14 cohort studies, n=270,229]
- Astley CM, Todd JN, Salem RM, et al. Genetic Evidence That Carbohydrate-Stimulated Insulin Secretion Leads to Obesity. Clin Chem. 2018;64(1):192-200. DOI: 10.1373/clinchem.2017.280727 · PMID: 29295838 [Genetic study, Mendelian randomization, genomic data and UK Biobank]
- Mehran AE, Templeman NM, Brigidi GS, et al. Hyperinsulinemia drives diet-induced obesity independently of brain insulin production. Cell Metab. 2012;16(6):723-37. DOI: 10.1016/j.cmet.2012.10.019 · PMID: 23217255 [In vivo, mouse]
- Weisberg SP, McCann D, Desai M, et al. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest. 2003;112(12):1796-808. DOI: 10.1172/JCI19246 · PMID: 14679176 [In vivo, mouse, supplemented by human fat tissue]
- Broussard JL, Ehrmann DA, Van Cauter E, Tasali E, Brady MJ. Impaired insulin signaling in human adipocytes after experimental sleep restriction: a randomized, crossover study. Ann Intern Med. 2012;157(8):549-57. DOI: 10.7326/0003-4819-157-8-201210160-00005 · PMID: 23070488 [RCT, crossover, n=7]
- Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346(6):393-403. DOI: 10.1056/NEJMoa012512 · PMID: 11832527 [RCT, n=3,234, Diabetes Prevention Program]
- Tuomilehto J, Lindström J, Eriksson JG, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001;344(18):1343-50. DOI: 10.1056/NEJM200105033441801 · PMID: 11333990 [RCT, n=522, Finnish Diabetes Prevention Study]
- Uusitupa M, Khan TA, Viguiliouk E, et al. Prevention of Type 2 Diabetes by Lifestyle Changes: A Systematic Review and Meta-Analysis. Nutrients. 2019;11(11):2611. DOI: 10.3390/nu11112611 · PMID: 31683759 [Meta-analysis, 7 RCTs, n=4,090]
- Lean MEJ, Leslie WS, Barnes AC, et al. Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial. Lancet. 2018;391(10120):541-551. DOI: 10.1016/S0140-6736(17)33102-1 · PMID: 29221645 [RCT, cluster-randomized, n=306]
- Lim EL, Hollingsworth KG, Aribisala BS, Chen MJ, Mathers JC, Taylor R. Reversal of type 2 diabetes: normalisation of beta cell function in association with decreased pancreas and liver triacylglycerol. Diabetologia. 2011;54(10):2506-14. DOI: 10.1007/s00125-011-2204-7 · PMID: 21656330 [Pathophysiology, non-randomized intervention study, n=11 plus 8 controls]
- Verheggen RJHM, Maessen MFH, Green DJ, et al. A systematic review and meta-analysis on the effects of exercise training versus hypocaloric diet: distinct effects on body weight and visceral adipose tissue. Obes Rev. 2016;17(8):664-90. DOI: 10.1111/obr.12406 · PMID: 27213481 [Meta-analysis, 117 studies, n=4,815]
- Johnson NA, Sachinwalla T, Walton DW, et al. Aerobic exercise training reduces hepatic and visceral lipids in obese individuals without weight loss. Hepatology. 2009;50(4):1105-12. DOI: 10.1002/hep.23129 · PMID: 19637289 [RCT, n=19]
- Hallsworth K, Fattakhova G, Hollingsworth KG, et al. Resistance exercise reduces liver fat and its mediators in non-alcoholic fatty liver disease independent of weight loss. Gut. 2011;60(9):1278-83. DOI: 10.1136/gut.2011.242073 · PMID: 21708823 [RCT, n=19]
- Sutton EF, Beyl R, Early KS, Cefalu WT, Ravussin E, Peterson CM. Early Time-Restricted Feeding Improves Insulin Sensitivity, Blood Pressure, and Oxidative Stress Even without Weight Loss in Men with Prediabetes. Cell Metab. 2018;27(6):1212-1221.e3. DOI: 10.1016/j.cmet.2018.04.010 · PMID: 29754952 [RCT, crossover, men with prediabetes]